Correcting dilated cardiomyopathy with fibroblast-targeted p38 deficiency
Ross C. Bretherton(California Institute for Regenerative Medicine), Jennifer Davis(University of Washington), Franziska Koser, Jagdambika Gunaje(University of Washington), Cole A. DeForest(California Institute for Regenerative Medicine), Alex J. Goldstein(University of Washington), Farid Moussavi‐Harami(University of Washington), Kristin A. Zabrecky(University of Washington), Amy Martinson(University of Washington), Kristina B. Kooiker(University of Washington), Timothy S. McMillen(Anna Needs Neuroblastoma Answers), Galina Flint(Mahindra and Mahindra Limited (India)), Wolfgang A. Linke(Ruhr University Bochum), Nathan J. Sniadecki(California Institute for Regenerative Medicine), Michael Regnier(University of Washington), Isabella M. Reichardt(University of Washington), Darrian Bugg(University of Washington), Elizabeth Plaster(University of Washington), Logan R.J. Bailey(University of Washington)
Cited by 5
Related Papers
Gigantic Business
|Circulation Research|2014|327
Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis
|Circulation|2017|301
Nicotinamide for the treatment of heart failure with preserved ejection fraction
|Science Translational Medicine|2021|207
Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues
|Journal of Molecular and Cellular Cardiology|2018|192
Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor–Deficient Mice
|Arteriosclerosis Thrombosis and Vascular Biology|2008|181